Cipla Ltd.

NSE: CIPLA  SECTOR: Pharmaceuticals & Drugs

946.6
+7.9 (0.84%)

Price Summary

Today's High

₹ 954.2

Today's Low

₹ 924.25

52 Week High

₹ 944.4

52 Week Low

₹ 565.9

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.

Company Essentials

Market Cap

76339.81399014 Cr.

Enterprise Value

75822.80399014 Cr.

No. of Shares

80.6463279 Cr.

P/E

28.71

P/B

3.91

Face Value

₹ 2

Div. Yield

0.42%

Book Value (TTM)

₹  242.2716

CASH

523.07 Cr.

DEBT

6.06 Cr.

Promoter Holding

36.7%

EPS (TTM)

₹  32.9766

Sales Growth

2.30434596383873%

ROE

14.0036849099915 %

ROCE

18.079396991889 %

Profit Growth

17.10152604066 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year2.3%
3 Year5.54%
5 Year4.55%

Profit Growth (in Cr.)

1 Year22.76%
3 Year33.47%
5 Year14.44%

ROE%

1 Year14%
3 Year12.55%
5 Year11.66%

ROCE %

1 Year18.08%
3 Year16.27%
5 Year14.59%

Debt/Equity

0.0003

Price to Cash Flow

37.83

Interest Cover Ratio

83.2277392510402

CFO/PAT (5 Yr. Avg.)

1.17087740933021

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2020 36.7 0
Sep 2020 36.7 0
Jun 2020 36.68 0
Mar 2020 36.68 0
Dec 2019 36.68 0
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 33.4716811613045% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 83.2277392510402.
  • Company has a healthy liquidity position with current ratio of 3.44637668986634.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 7.28817320948896.

 Limitations

  • The company has shown a poor revenue growth of 5.53987584372311% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
Net Sales 2926.2 3133.44 3128.02 3807.89 3731.55
Total Expenditure 2489.26 2668.64 2183.28 2676.92 2735.4
Operating Profit 436.94 464.8 944.74 1130.97 996.15
Other Income 73.28 413.41 45.66 39.17 96.12
Interest 9.55 9.24 14.21 11.69 10.33
Depreciation 143.14 160.42 143.73 140.8 134.57
Exceptional Items 0 0 0 0 0
Profit Before Tax 357.53 708.55 832.46 1017.65 947.37
Tax 75.31 103.98 222.16 272.01 248.44
Profit After Tax 282.22 604.57 610.3 745.64 698.93
Adjusted EPS (Rs) 0.35 0.75 0.76 0.92 0.87

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 11950.69 10768.49 11389.9 12374.01 12659.15
Total Expenditure 9897.26 9172.23 9194.35 9879.69 9991.76
Operating Profit 2053.43 1596.26 2195.55 2494.32 2667.39
Other Income 280.3 129.85 334.88 577.52 913.76
Interest 147.07 39.2 11.9 16.97 36.05
Depreciation 442.69 499.97 529.61 562.04 580.79
Exceptional Items 0 0 -77.52 0 0
Profit Before Tax 1743.97 1186.94 1911.4 2492.83 2964.31
Tax 281.67 212 442.88 604.42 646.14
Net Profit 1462.3 974.94 1468.52 1888.41 2318.17
Adjusted EPS (Rs.) 18.2 12.12 18.24 23.44 28.75

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 160.68 160.9 161.02 161.14 161.25
Total Reserves 11825.2 12639.61 13952.5 15620.77 17241.71
Borrowings 0.13 0.07 0 0 0
Other N/C liabilities 298.57 191.27 202.95 268.82 383.41
Current liabilities 2954.47 2555.83 2731.7 2368.08 2619.29
Total Liabilities 15239.05 15547.68 17048.17 18418.81 20405.66
Assets
Net Block 3826.11 4235.26 4320.03 4127.46 4024.54
Capital WIP 512.81 540.52 435.28 241.32 255.73
Investments 3716.59 3648.03 3597.56 3865.46 6481.76
Loans & Advances 551.69 624.98 611.43 583.23 516.63
Other N/C Assets 164.48 153.55 145.7 122.69 99.94
Current Assets 6467.37 6345.34 7938.17 9478.65 9027.06
Total Assets 15239.05 15547.68 17048.17 18418.81 20405.66
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit Before Tax 1743.97 1186.94 1911.4 2492.83 2964.31
Adjustment 473.89 778.6 315.64 187.6 -35.73
Working Capital Changes -98.83 573.12 -588 -761 -245.46
Tax Paid -390.63 -331.27 -522.51 -451.38 -664.98
Operating Cash Flow 1728.4 2207.39 1116.53 1468.05 2018.14
Investing Cash Flow -1205.67 -1191.25 -592.16 -1147.05 -1126.33
Financing Cash Flow -547 -1010.8 -350.96 -473.32 -693.89
Net Cash Flow -24.27 5.34 173.41 -152.32 197.92

Corporate Actions

Ratings & Research Reports

Company Presentations

Company News

Cipla Stock Price Analysis and Quick Research Report. Is Cipla an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Cipla and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 2018.14 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Cipla has a Debt to Equity ratio of 0.0003 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Cipla , the EPS growth was 22.6741928739958 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Cipla has OPM of 19.6777801220773 % which is a good sign for profitability.
     
  • ROE: Cipla have a average ROE of 14.0036849099915 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Cipla

X